Daily Alpha · Reddit
· Premarket Alpha · by Buzzberg Research
The most substantive threads were the FICO-VantageScore moat fight, IRDAI's commission consultation and PB Fintech's drop, AI storage and wafer supply tightness, and option-implied SPY optimism.
Themes on this desk
FICO vs VantageScore
A mortgage-lender employee says a large lender will roll out VantageScore at contract renewal and that Rocket already uses Vantage, while bulls point to decades of performance data and Dodd-Frank entrenchment and others argue the bi-merge s
India insurance distribution
IRDAI's consultation on commission and expense caps drove PB Fintech down about 26% in a day and across its full 52-week range in two sessions.
AI storage and wafer supply
Kioxia launched the first PCIe 6.0 enterprise SSDs on 10th-generation BiCS FLASH, a post argued QLC's hyperscale moment has arrived, and silicon wafer prices are forecast to surge 40% in 2027.
Highest engagement
by score · day changeChevron positioned for surging Venezuelan crude imports and $7B investment
Post argues Chevron plans to invest $7 billion in Venezuela over five years targeting production above 600,000 barrels per day at costs below $20 per barrel, as U.S. imports of Venezuelan crude surged 237% over six months to 782,000 barrels per day, the highest weekly level since 2017, with Trump planning to use Venezuelan oil to refill the SPR.
\\- CVX plans to invest $7 billion in Venezuela over five years, targeting production above 600,000 barrels per day at
Low-cost barrels plus government demand would add upstream volume and reserve life at a major integrated, a differentiated growth vector versus peers.
Watch Confirm via EIA weekly import data sustaining near 782,000 bpd and Chevron disclosure of Venezuela production progress toward 600,000 bpd.
Source →Lennar below book value with liquidation value above market cap
Author argues Lennar trades below 1x price-to-book with the entire market cap below balance-sheet equity, citing a stock price of $81 versus fair market value at liquidation of $91, roughly 12% 'free money', and frames the U.S. housing shortage as the next bottleneck after AI bottlenecks; the stated bear case is that rising rates slow home buying, which LEN mitigates by buying down rates and taking share from smaller builders.
Right now the stock is at $81 its fmv at liquidation is $91.
A large-cap homebuilder at sub-book valuation with a rate-buydown share-gain mechanism is a concrete value-versus-cycle debate rather than a sentiment trade.
Watch Confirm via Lennar's reported book value, gross margins, and order trends; invalidation is book value impairment or continued order declines despite buydowns.
Source →Domino's near bottom of multiple reset at ~8x P/E with $1.2B buyback
Author argues DPZ is near the bottom of its multiple reset with a P/E around 8x, less than peers, with a $1.2B authorized share buyback program, historically strong free cash flow plus dividend yield and buybacks, and discloses scaling into a small position at an average of 292.75.
Just gonna say, It looks like DPZ (Domino's) is near the bottom of its multiple reset with a p/e \~8x
A disclosed entry price and multiple versus peers makes this a checkable valuation claim on a large-cap consumer name with capital-return support.
Watch Confirm via DPZ's reported P/E and FCF against peers and buyback execution; invalidation is multiple compression continuing without earnings stabilization.
Source →GRAIL advisory committee votes split, approval expected next year
Author reports the advisory committee votes for GRAIL: safety 10-0 yes, effectiveness 6-4 yes to no, and benefits to risk 7 yes, 2 no, 1 abstain, and guesses FDA approval next year while noting disclosures will be tight; views it as positive for multi-cancer detection though not necessarily early detection.
* For safety - yes voted 10-0 * Effectiveness was 6-4 Yes to No * Benefits to Risk was voted
A split effectiveness vote with a favorable risk-benefit tally is a specific regulatory signal that shifts approval odds for a multi-cancer screening product.
Watch Confirm via the FDA's actual action date and label scope; invalidation is a complete response letter or a narrow indication excluding early detection.
Source →Atlassian short thesis invalidated as AI-context demand drives results beat
Poster recounts that six months ago the market called SaaS dead and targeted TEAM, whose seat-based collaboration software was said to be replaceable by AI agents; TEAM fell to $56, cut 10% of staff in March and was still -36% YTD on 6 August, then reported FY26 revenue +26%, Q4 cloud accelerating to +31%, RPO +44% and FCF $1.32B, and the stock rose 30% the next day to a last close of $195. The poster argues the short was wrong because AI agents need context that lives in the system of record, citing Atlassian's MCP server hitting 1M monthly active users, doubling in a quarter.
Then announced FY26 results with revenue +26%, Q4 cloud accelerating to +31%, RPO +44%, FCF $1.32B.
A concrete, dated refutation of the 'AI kills seat-based SaaS' trade, with the mechanism (agents querying the system of record) that could re-rate other workflow-software names the market has de-rated on the same premise.
Watch Whether TEAM holds its post-earnings gains and whether MCP/agent-driven usage keeps compounding; a reversal in cloud growth or RPO would undercut the context-moat argument.
Source →Most argued
by comments per upvoteNSE options share loss to BSE framed as the key listing-year risk
Poster argues 60% of NSE's revenues come from the options market, where NSE's share has been declining for a couple of years while BSE's share has been rising, which drove BSE's stock up 695% in three years; the poster expects up to 60% gains in NSE's first year after listing because one-off SEBI settlements depressed YE 31.03.2026 profits and the PE is not reflective of real profitability, but does not believe NSE is a multibagger because it must first win back options share and then compound profits above 30% CAGR for years.
60% of NSE's revenues come from Options market and that is an area where NSE's market share has been declining
Frames the NSE listing as a near-term earnings-normalization trade with a structural share-loss overhang, and identifies BSE as the share gainer that already re-rated.
Watch NSE/BSE options market-share data and NSE's post-listing quarterly results versus the one-off-depressed base.
Source →Vistra cited as AI data-center power play with prominent disclosed buyers
Poster notes VST is currently at 138 and has made deals with Meta for AI data centers, and that Peter Thiel, Trump and Pelosi all bought into it between January and March.
Its currently at 138, and has made deals with Meta for AI data centers. Opinions?
Links a power producer directly to hyperscaler data-center demand with named political/financial buyers, a demand-side read-through for AI electricity suppliers.
Watch Confirmation of the Meta data-center agreements and their contracted capacity/revenue terms; further disclosed purchases in filings.
Source →BlackBerry Alloy Kore wins first $100M+ commercial-vehicle contract
Poster says BlackBerry's new Alloy Kore automotive foundational platform won its first contract worth $100M+ for a commercial-vehicle group, and that the $100M+ is expected revenue based on projected vehicle production rather than an up-front payment, with some revenue before production and royalties after.
The $100M+ is actually expected revenue from the deal based on the number vehicles expected to be produced, not an
First commercial validation of BlackBerry's pivot from IVY middleware to a full automotive software platform; revenue recognition is back-end loaded, so near-term cash impact is smaller than the headline figure implies.
Watch Company confirmation of the award and disclosure of the customer; evidence of production volumes converting the $100M+ expected revenue into recognized royalties.
Source →Palantir bear case framed on 84x forward earnings and ~138x sales
Poster leans bearish on Palantir specifically, citing roughly 84x forward earnings and about 138x sales, arguing the market already assumes years of strong growth and execution and that the stock has little room for an ordinary slowdown or merely good quarter.
It's currently trading around 84x forward earnings and roughly 138x sales in the latest data, which means the market is
Frames PLTR as a valuation-duration risk rather than a business-quality risk: multiple compression can occur without any fundamental deterioration.
Watch Forward multiple trajectory versus growth deceleration; a quarter of slowing net-new or margin miss would be the trigger the poster identifies.
Source →Liontown profitable with net cash while share price fell on lithium prices
A detailed bullish case argues LTR went from $567m net debt to $192m net cash, posted its first profit, hit all FY26 guidance, and finished moving fully underground, while the share price fell ~60% purely on lower carbonate prices; the chairman bought another 1m shares at ~$1.22.
cash, posted its first ever profit, hit all of its FY26 guidance and finished moving the mine fully underground *
If the business improvement is real and lithium prices mean-revert, LTR could re-rate sharply; the divergence between operational delivery and share price is the core mispricing claim.
Watch The end-of-September 4.0Mtpa FID and the October 30 quarterly price print would confirm the ramp; further lithium price declines or cost overruns would falsify.
Source →